nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—SIGMAR1—Raloxifene—osteoporosis	0.111	0.164	CbGbCtD
Amitriptyline—HTR6—Raloxifene—osteoporosis	0.0829	0.123	CbGbCtD
Amitriptyline—ALB—Estropipate—osteoporosis	0.0439	0.0653	CbGbCtD
Amitriptyline—CYP2B6—Raloxifene—osteoporosis	0.0299	0.0445	CbGbCtD
Amitriptyline—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0289	0.0429	CbGbCtD
Amitriptyline—CYP1A2—Estropipate—osteoporosis	0.0263	0.0391	CbGbCtD
Amitriptyline—CYP2C9—Estropipate—osteoporosis	0.0237	0.0352	CbGbCtD
Amitriptyline—CYP2B6—Cholecalciferol—osteoporosis	0.0231	0.0343	CbGbCtD
Amitriptyline—CYP2C8—Raloxifene—osteoporosis	0.0226	0.0337	CbGbCtD
Amitriptyline—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0219	0.0325	CbGbCtD
Amitriptyline—ALB—Estradiol—osteoporosis	0.0182	0.0271	CbGbCtD
Amitriptyline—CYP2C8—Cholecalciferol—osteoporosis	0.0175	0.026	CbGbCtD
Amitriptyline—ABCB1—Ethinyl Estradiol—osteoporosis	0.0148	0.022	CbGbCtD
Amitriptyline—CYP2C19—Cholecalciferol—osteoporosis	0.0147	0.0218	CbGbCtD
Amitriptyline—CYP3A5—Estradiol—osteoporosis	0.0147	0.0218	CbGbCtD
Amitriptyline—CYP2C8—Estradiol—osteoporosis	0.0141	0.021	CbGbCtD
Amitriptyline—CYP3A4—Estropipate—osteoporosis	0.0138	0.0205	CbGbCtD
Amitriptyline—CYP3A4—Calcitriol—osteoporosis	0.0138	0.0205	CbGbCtD
Amitriptyline—CYP1A2—Conjugated Estrogens—osteoporosis	0.0124	0.0185	CbGbCtD
Amitriptyline—CYP2C9—Cholecalciferol—osteoporosis	0.0122	0.0181	CbGbCtD
Amitriptyline—CYP2C19—Estradiol—osteoporosis	0.0118	0.0176	CbGbCtD
Amitriptyline—CYP2D6—Cholecalciferol—osteoporosis	0.0112	0.0166	CbGbCtD
Amitriptyline—CYP3A4—Ergocalciferol—osteoporosis	0.011	0.0164	CbGbCtD
Amitriptyline—CYP1A2—Estradiol—osteoporosis	0.0109	0.0162	CbGbCtD
Amitriptyline—ABCB1—Conjugated Estrogens—osteoporosis	0.0109	0.0162	CbGbCtD
Amitriptyline—CYP2C9—Estradiol—osteoporosis	0.00983	0.0146	CbGbCtD
Amitriptyline—ABCB1—Estradiol—osteoporosis	0.00954	0.0142	CbGbCtD
Amitriptyline—CYP3A4—Raloxifene—osteoporosis	0.00919	0.0137	CbGbCtD
Amitriptyline—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00887	0.0132	CbGbCtD
Amitriptyline—CYP3A4—Cholecalciferol—osteoporosis	0.00709	0.0105	CbGbCtD
Amitriptyline—CYP3A4—Conjugated Estrogens—osteoporosis	0.00651	0.00968	CbGbCtD
Amitriptyline—CYP3A4—Estradiol—osteoporosis	0.00572	0.0085	CbGbCtD
Amitriptyline—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00152	1	CbGdCrCtD
Amitriptyline—Malaise—Pamidronate—osteoporosis	0.000357	0.0019	CcSEcCtD
Amitriptyline—Fatigue—Ibandronate—osteoporosis	0.000356	0.00189	CcSEcCtD
Amitriptyline—Syncope—Pamidronate—osteoporosis	0.000355	0.00189	CcSEcCtD
Amitriptyline—Leukopenia—Pamidronate—osteoporosis	0.000354	0.00189	CcSEcCtD
Amitriptyline—Dysgeusia—Zoledronate—osteoporosis	0.000354	0.00189	CcSEcCtD
Amitriptyline—Alopecia—Conjugated Estrogens—osteoporosis	0.000353	0.00188	CcSEcCtD
Amitriptyline—Anxiety—Risedronate—osteoporosis	0.000353	0.00188	CcSEcCtD
Amitriptyline—Constipation—Ibandronate—osteoporosis	0.000353	0.00188	CcSEcCtD
Amitriptyline—Pruritus—Etidronic acid—osteoporosis	0.000352	0.00187	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Estradiol—osteoporosis	0.000352	0.00187	CcSEcCtD
Amitriptyline—Decreased appetite—Calcitriol—osteoporosis	0.000351	0.00187	CcSEcCtD
Amitriptyline—Myocardial infarction—Estradiol—osteoporosis	0.00035	0.00186	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Estradiol—osteoporosis	0.00035	0.00186	CcSEcCtD
Amitriptyline—Feeling abnormal—Alendronate—osteoporosis	0.000349	0.00186	CcSEcCtD
Amitriptyline—Oedema—Ethinyl Estradiol—osteoporosis	0.000349	0.00186	CcSEcCtD
Amitriptyline—Loss of consciousness—Pamidronate—osteoporosis	0.000348	0.00185	CcSEcCtD
Amitriptyline—Jaundice—Estradiol—osteoporosis	0.000348	0.00185	CcSEcCtD
Amitriptyline—Dry mouth—Risedronate—osteoporosis	0.000347	0.00185	CcSEcCtD
Amitriptyline—Constipation—Calcitriol—osteoporosis	0.000345	0.00184	CcSEcCtD
Amitriptyline—Convulsion—Pamidronate—osteoporosis	0.000343	0.00183	CcSEcCtD
Amitriptyline—Hypertension—Pamidronate—osteoporosis	0.000342	0.00182	CcSEcCtD
Amitriptyline—Urticaria—Estropipate—osteoporosis	0.000342	0.00182	CcSEcCtD
Amitriptyline—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000341	0.00182	CcSEcCtD
Amitriptyline—Vision blurred—Zoledronate—osteoporosis	0.000341	0.00181	CcSEcCtD
Amitriptyline—Diarrhoea—Etidronic acid—osteoporosis	0.00034	0.00181	CcSEcCtD
Amitriptyline—Body temperature increased—Estropipate—osteoporosis	0.00034	0.00181	CcSEcCtD
Amitriptyline—Feeling abnormal—Ibandronate—osteoporosis	0.00034	0.00181	CcSEcCtD
Amitriptyline—Tremor—Zoledronate—osteoporosis	0.000339	0.0018	CcSEcCtD
Amitriptyline—Urticaria—Alendronate—osteoporosis	0.000336	0.00179	CcSEcCtD
Amitriptyline—Anxiety—Pamidronate—osteoporosis	0.000336	0.00179	CcSEcCtD
Amitriptyline—Ill-defined disorder—Zoledronate—osteoporosis	0.000336	0.00179	CcSEcCtD
Amitriptyline—Body temperature increased—Alendronate—osteoporosis	0.000335	0.00178	CcSEcCtD
Amitriptyline—Shock—Risedronate—osteoporosis	0.000334	0.00178	CcSEcCtD
Amitriptyline—Discomfort—Pamidronate—osteoporosis	0.000333	0.00177	CcSEcCtD
Amitriptyline—Agitation—Zoledronate—osteoporosis	0.000332	0.00177	CcSEcCtD
Amitriptyline—Body temperature increased—Raloxifene—osteoporosis	0.000329	0.00175	CcSEcCtD
Amitriptyline—Vision blurred—Conjugated Estrogens—osteoporosis	0.000328	0.00175	CcSEcCtD
Amitriptyline—Urticaria—Ibandronate—osteoporosis	0.000328	0.00174	CcSEcCtD
Amitriptyline—Malaise—Zoledronate—osteoporosis	0.000326	0.00174	CcSEcCtD
Amitriptyline—Body temperature increased—Ibandronate—osteoporosis	0.000326	0.00174	CcSEcCtD
Amitriptyline—Confusional state—Pamidronate—osteoporosis	0.000326	0.00173	CcSEcCtD
Amitriptyline—Syncope—Zoledronate—osteoporosis	0.000324	0.00173	CcSEcCtD
Amitriptyline—Leukopenia—Zoledronate—osteoporosis	0.000324	0.00172	CcSEcCtD
Amitriptyline—Oedema—Pamidronate—osteoporosis	0.000323	0.00172	CcSEcCtD
Amitriptyline—Urticaria—Calcitriol—osteoporosis	0.000321	0.00171	CcSEcCtD
Amitriptyline—Hepatitis—Estradiol—osteoporosis	0.00032	0.0017	CcSEcCtD
Amitriptyline—Palpitations—Zoledronate—osteoporosis	0.00032	0.0017	CcSEcCtD
Amitriptyline—Body temperature increased—Calcitriol—osteoporosis	0.000319	0.0017	CcSEcCtD
Amitriptyline—Hypoaesthesia—Estradiol—osteoporosis	0.000319	0.0017	CcSEcCtD
Amitriptyline—Shock—Pamidronate—osteoporosis	0.000318	0.00169	CcSEcCtD
Amitriptyline—Loss of consciousness—Zoledronate—osteoporosis	0.000318	0.00169	CcSEcCtD
Amitriptyline—Thrombocytopenia—Pamidronate—osteoporosis	0.000316	0.00168	CcSEcCtD
Amitriptyline—Vomiting—Etidronic acid—osteoporosis	0.000316	0.00168	CcSEcCtD
Amitriptyline—Tachycardia—Pamidronate—osteoporosis	0.000315	0.00168	CcSEcCtD
Amitriptyline—Rash—Etidronic acid—osteoporosis	0.000313	0.00167	CcSEcCtD
Amitriptyline—Convulsion—Zoledronate—osteoporosis	0.000313	0.00167	CcSEcCtD
Amitriptyline—Dermatitis—Etidronic acid—osteoporosis	0.000313	0.00167	CcSEcCtD
Amitriptyline—Hyperhidrosis—Pamidronate—osteoporosis	0.000312	0.00166	CcSEcCtD
Amitriptyline—Syncope—Conjugated Estrogens—osteoporosis	0.000312	0.00166	CcSEcCtD
Amitriptyline—Hypertension—Zoledronate—osteoporosis	0.000312	0.00166	CcSEcCtD
Amitriptyline—Headache—Etidronic acid—osteoporosis	0.000311	0.00166	CcSEcCtD
Amitriptyline—Asthenia—Estropipate—osteoporosis	0.000309	0.00164	CcSEcCtD
Amitriptyline—Anorexia—Pamidronate—osteoporosis	0.000308	0.00164	CcSEcCtD
Amitriptyline—Palpitations—Conjugated Estrogens—osteoporosis	0.000308	0.00164	CcSEcCtD
Amitriptyline—Insomnia—Risedronate—osteoporosis	0.000307	0.00164	CcSEcCtD
Amitriptyline—Anxiety—Zoledronate—osteoporosis	0.000307	0.00163	CcSEcCtD
Amitriptyline—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000306	0.00163	CcSEcCtD
Amitriptyline—Paraesthesia—Risedronate—osteoporosis	0.000305	0.00163	CcSEcCtD
Amitriptyline—Pruritus—Estropipate—osteoporosis	0.000304	0.00162	CcSEcCtD
Amitriptyline—Discomfort—Zoledronate—osteoporosis	0.000304	0.00162	CcSEcCtD
Amitriptyline—Asthenia—Alendronate—osteoporosis	0.000304	0.00162	CcSEcCtD
Amitriptyline—Hypotension—Pamidronate—osteoporosis	0.000302	0.00161	CcSEcCtD
Amitriptyline—Convulsion—Conjugated Estrogens—osteoporosis	0.000302	0.00161	CcSEcCtD
Amitriptyline—Dry mouth—Zoledronate—osteoporosis	0.000301	0.0016	CcSEcCtD
Amitriptyline—Fatigue—Ethinyl Estradiol—osteoporosis	0.000301	0.0016	CcSEcCtD
Amitriptyline—Pruritus—Alendronate—osteoporosis	0.0003	0.0016	CcSEcCtD
Amitriptyline—Dyspepsia—Risedronate—osteoporosis	0.000299	0.00159	CcSEcCtD
Amitriptyline—Tinnitus—Estradiol—osteoporosis	0.000298	0.00159	CcSEcCtD
Amitriptyline—Constipation—Ethinyl Estradiol—osteoporosis	0.000298	0.00159	CcSEcCtD
Amitriptyline—Confusional state—Zoledronate—osteoporosis	0.000298	0.00158	CcSEcCtD
Amitriptyline—Asthenia—Ibandronate—osteoporosis	0.000296	0.00158	CcSEcCtD
Amitriptyline—Anxiety—Conjugated Estrogens—osteoporosis	0.000295	0.00157	CcSEcCtD
Amitriptyline—Nausea—Etidronic acid—osteoporosis	0.000295	0.00157	CcSEcCtD
Amitriptyline—Oedema—Zoledronate—osteoporosis	0.000295	0.00157	CcSEcCtD
Amitriptyline—Diarrhoea—Estropipate—osteoporosis	0.000294	0.00157	CcSEcCtD
Amitriptyline—Fatigue—Risedronate—osteoporosis	0.000293	0.00156	CcSEcCtD
Amitriptyline—Insomnia—Pamidronate—osteoporosis	0.000292	0.00156	CcSEcCtD
Amitriptyline—Pruritus—Ibandronate—osteoporosis	0.000292	0.00155	CcSEcCtD
Amitriptyline—Constipation—Risedronate—osteoporosis	0.000291	0.00155	CcSEcCtD
Amitriptyline—Shock—Zoledronate—osteoporosis	0.00029	0.00155	CcSEcCtD
Amitriptyline—Paraesthesia—Pamidronate—osteoporosis	0.00029	0.00154	CcSEcCtD
Amitriptyline—Diarrhoea—Alendronate—osteoporosis	0.00029	0.00154	CcSEcCtD
Amitriptyline—Asthenia—Calcitriol—osteoporosis	0.00029	0.00154	CcSEcCtD
Amitriptyline—Thrombocytopenia—Zoledronate—osteoporosis	0.000289	0.00154	CcSEcCtD
Amitriptyline—Tachycardia—Zoledronate—osteoporosis	0.000288	0.00153	CcSEcCtD
Amitriptyline—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000287	0.00153	CcSEcCtD
Amitriptyline—Somnolence—Pamidronate—osteoporosis	0.000287	0.00153	CcSEcCtD
Amitriptyline—Pruritus—Calcitriol—osteoporosis	0.000286	0.00152	CcSEcCtD
Amitriptyline—Hyperhidrosis—Zoledronate—osteoporosis	0.000285	0.00152	CcSEcCtD
Amitriptyline—Diarrhoea—Raloxifene—osteoporosis	0.000285	0.00152	CcSEcCtD
Amitriptyline—Dyspepsia—Pamidronate—osteoporosis	0.000284	0.00151	CcSEcCtD
Amitriptyline—Dizziness—Estropipate—osteoporosis	0.000284	0.00151	CcSEcCtD
Amitriptyline—Oedema—Conjugated Estrogens—osteoporosis	0.000284	0.00151	CcSEcCtD
Amitriptyline—Alopecia—Estradiol—osteoporosis	0.000283	0.00151	CcSEcCtD
Amitriptyline—Diarrhoea—Ibandronate—osteoporosis	0.000282	0.0015	CcSEcCtD
Amitriptyline—Anorexia—Zoledronate—osteoporosis	0.000281	0.0015	CcSEcCtD
Amitriptyline—Decreased appetite—Pamidronate—osteoporosis	0.000281	0.0015	CcSEcCtD
Amitriptyline—Dizziness—Alendronate—osteoporosis	0.00028	0.00149	CcSEcCtD
Amitriptyline—Shock—Conjugated Estrogens—osteoporosis	0.00028	0.00149	CcSEcCtD
Amitriptyline—Fatigue—Pamidronate—osteoporosis	0.000279	0.00148	CcSEcCtD
Amitriptyline—Tachycardia—Conjugated Estrogens—osteoporosis	0.000277	0.00148	CcSEcCtD
Amitriptyline—Urticaria—Ethinyl Estradiol—osteoporosis	0.000277	0.00147	CcSEcCtD
Amitriptyline—Constipation—Pamidronate—osteoporosis	0.000276	0.00147	CcSEcCtD
Amitriptyline—Diarrhoea—Calcitriol—osteoporosis	0.000276	0.00147	CcSEcCtD
Amitriptyline—Hypotension—Zoledronate—osteoporosis	0.000276	0.00147	CcSEcCtD
Amitriptyline—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000276	0.00147	CcSEcCtD
Amitriptyline—Dizziness—Raloxifene—osteoporosis	0.000275	0.00147	CcSEcCtD
Amitriptyline—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000275	0.00146	CcSEcCtD
Amitriptyline—Vomiting—Estropipate—osteoporosis	0.000273	0.00146	CcSEcCtD
Amitriptyline—Dysgeusia—Estradiol—osteoporosis	0.000273	0.00145	CcSEcCtD
Amitriptyline—Dizziness—Ibandronate—osteoporosis	0.000273	0.00145	CcSEcCtD
Amitriptyline—Rash—Estropipate—osteoporosis	0.000271	0.00144	CcSEcCtD
Amitriptyline—Dermatitis—Estropipate—osteoporosis	0.000271	0.00144	CcSEcCtD
Amitriptyline—Anorexia—Conjugated Estrogens—osteoporosis	0.000271	0.00144	CcSEcCtD
Amitriptyline—Urticaria—Risedronate—osteoporosis	0.00027	0.00144	CcSEcCtD
Amitriptyline—Headache—Estropipate—osteoporosis	0.000269	0.00143	CcSEcCtD
Amitriptyline—Vomiting—Alendronate—osteoporosis	0.000269	0.00143	CcSEcCtD
Amitriptyline—Body temperature increased—Risedronate—osteoporosis	0.000269	0.00143	CcSEcCtD
Amitriptyline—Rash—Alendronate—osteoporosis	0.000267	0.00142	CcSEcCtD
Amitriptyline—Insomnia—Zoledronate—osteoporosis	0.000267	0.00142	CcSEcCtD
Amitriptyline—Dermatitis—Alendronate—osteoporosis	0.000267	0.00142	CcSEcCtD
Amitriptyline—Feeling abnormal—Pamidronate—osteoporosis	0.000266	0.00142	CcSEcCtD
Amitriptyline—Hypotension—Conjugated Estrogens—osteoporosis	0.000266	0.00141	CcSEcCtD
Amitriptyline—Headache—Alendronate—osteoporosis	0.000265	0.00141	CcSEcCtD
Amitriptyline—Paraesthesia—Zoledronate—osteoporosis	0.000265	0.00141	CcSEcCtD
Amitriptyline—Vomiting—Raloxifene—osteoporosis	0.000265	0.00141	CcSEcCtD
Amitriptyline—Rash—Raloxifene—osteoporosis	0.000263	0.0014	CcSEcCtD
Amitriptyline—Dermatitis—Raloxifene—osteoporosis	0.000262	0.0014	CcSEcCtD
Amitriptyline—Somnolence—Zoledronate—osteoporosis	0.000262	0.0014	CcSEcCtD
Amitriptyline—Vomiting—Ibandronate—osteoporosis	0.000262	0.0014	CcSEcCtD
Amitriptyline—Tremor—Estradiol—osteoporosis	0.000261	0.00139	CcSEcCtD
Amitriptyline—Headache—Raloxifene—osteoporosis	0.000261	0.00139	CcSEcCtD
Amitriptyline—Rash—Ibandronate—osteoporosis	0.00026	0.00138	CcSEcCtD
Amitriptyline—Dermatitis—Ibandronate—osteoporosis	0.00026	0.00138	CcSEcCtD
Amitriptyline—Dyspepsia—Zoledronate—osteoporosis	0.00026	0.00138	CcSEcCtD
Amitriptyline—Ill-defined disorder—Estradiol—osteoporosis	0.000259	0.00138	CcSEcCtD
Amitriptyline—Headache—Ibandronate—osteoporosis	0.000258	0.00138	CcSEcCtD
Amitriptyline—Insomnia—Conjugated Estrogens—osteoporosis	0.000257	0.00137	CcSEcCtD
Amitriptyline—Vomiting—Calcitriol—osteoporosis	0.000257	0.00137	CcSEcCtD
Amitriptyline—Decreased appetite—Zoledronate—osteoporosis	0.000257	0.00137	CcSEcCtD
Amitriptyline—Agitation—Estradiol—osteoporosis	0.000256	0.00136	CcSEcCtD
Amitriptyline—Nausea—Estropipate—osteoporosis	0.000255	0.00136	CcSEcCtD
Amitriptyline—Body temperature increased—Pamidronate—osteoporosis	0.000255	0.00136	CcSEcCtD
Amitriptyline—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000255	0.00136	CcSEcCtD
Amitriptyline—Rash—Calcitriol—osteoporosis	0.000255	0.00136	CcSEcCtD
Amitriptyline—Fatigue—Zoledronate—osteoporosis	0.000254	0.00135	CcSEcCtD
Amitriptyline—Dermatitis—Calcitriol—osteoporosis	0.000254	0.00135	CcSEcCtD
Amitriptyline—Headache—Calcitriol—osteoporosis	0.000253	0.00135	CcSEcCtD
Amitriptyline—Somnolence—Conjugated Estrogens—osteoporosis	0.000253	0.00135	CcSEcCtD
Amitriptyline—Constipation—Zoledronate—osteoporosis	0.000252	0.00134	CcSEcCtD
Amitriptyline—Nausea—Alendronate—osteoporosis	0.000252	0.00134	CcSEcCtD
Amitriptyline—Malaise—Estradiol—osteoporosis	0.000251	0.00134	CcSEcCtD
Amitriptyline—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00025	0.00133	CcSEcCtD
Amitriptyline—Asthenia—Ethinyl Estradiol—osteoporosis	0.00025	0.00133	CcSEcCtD
Amitriptyline—Syncope—Estradiol—osteoporosis	0.00025	0.00133	CcSEcCtD
Amitriptyline—Nausea—Raloxifene—osteoporosis	0.000247	0.00132	CcSEcCtD
Amitriptyline—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000247	0.00132	CcSEcCtD
Amitriptyline—Pruritus—Ethinyl Estradiol—osteoporosis	0.000247	0.00131	CcSEcCtD
Amitriptyline—Palpitations—Estradiol—osteoporosis	0.000246	0.00131	CcSEcCtD
Amitriptyline—Fatigue—Conjugated Estrogens—osteoporosis	0.000245	0.0013	CcSEcCtD
Amitriptyline—Nausea—Ibandronate—osteoporosis	0.000245	0.0013	CcSEcCtD
Amitriptyline—Loss of consciousness—Estradiol—osteoporosis	0.000245	0.0013	CcSEcCtD
Amitriptyline—Asthenia—Risedronate—osteoporosis	0.000244	0.0013	CcSEcCtD
Amitriptyline—Feeling abnormal—Zoledronate—osteoporosis	0.000243	0.0013	CcSEcCtD
Amitriptyline—Constipation—Conjugated Estrogens—osteoporosis	0.000243	0.00129	CcSEcCtD
Amitriptyline—Hypertension—Estradiol—osteoporosis	0.000241	0.00128	CcSEcCtD
Amitriptyline—Pruritus—Risedronate—osteoporosis	0.00024	0.00128	CcSEcCtD
Amitriptyline—Nausea—Calcitriol—osteoporosis	0.00024	0.00128	CcSEcCtD
Amitriptyline—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000239	0.00127	CcSEcCtD
Amitriptyline—Anxiety—Estradiol—osteoporosis	0.000236	0.00126	CcSEcCtD
Amitriptyline—Urticaria—Zoledronate—osteoporosis	0.000234	0.00125	CcSEcCtD
Amitriptyline—Discomfort—Estradiol—osteoporosis	0.000234	0.00125	CcSEcCtD
Amitriptyline—Body temperature increased—Zoledronate—osteoporosis	0.000233	0.00124	CcSEcCtD
Amitriptyline—Diarrhoea—Risedronate—osteoporosis	0.000233	0.00124	CcSEcCtD
Amitriptyline—Dry mouth—Estradiol—osteoporosis	0.000232	0.00124	CcSEcCtD
Amitriptyline—Asthenia—Pamidronate—osteoporosis	0.000232	0.00123	CcSEcCtD
Amitriptyline—Dizziness—Ethinyl Estradiol—osteoporosis	0.000231	0.00123	CcSEcCtD
Amitriptyline—Confusional state—Estradiol—osteoporosis	0.000229	0.00122	CcSEcCtD
Amitriptyline—Pruritus—Pamidronate—osteoporosis	0.000229	0.00122	CcSEcCtD
Amitriptyline—Oedema—Estradiol—osteoporosis	0.000227	0.00121	CcSEcCtD
Amitriptyline—Urticaria—Conjugated Estrogens—osteoporosis	0.000226	0.0012	CcSEcCtD
Amitriptyline—Dizziness—Risedronate—osteoporosis	0.000225	0.0012	CcSEcCtD
Amitriptyline—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000225	0.0012	CcSEcCtD
Amitriptyline—Shock—Estradiol—osteoporosis	0.000224	0.00119	CcSEcCtD
Amitriptyline—Tachycardia—Estradiol—osteoporosis	0.000222	0.00118	CcSEcCtD
Amitriptyline—Vomiting—Ethinyl Estradiol—osteoporosis	0.000222	0.00118	CcSEcCtD
Amitriptyline—Diarrhoea—Pamidronate—osteoporosis	0.000221	0.00118	CcSEcCtD
Amitriptyline—Hyperhidrosis—Estradiol—osteoporosis	0.00022	0.00117	CcSEcCtD
Amitriptyline—Rash—Ethinyl Estradiol—osteoporosis	0.00022	0.00117	CcSEcCtD
Amitriptyline—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00022	0.00117	CcSEcCtD
Amitriptyline—Headache—Ethinyl Estradiol—osteoporosis	0.000218	0.00116	CcSEcCtD
Amitriptyline—Vomiting—Risedronate—osteoporosis	0.000216	0.00115	CcSEcCtD
Amitriptyline—Rash—Risedronate—osteoporosis	0.000214	0.00114	CcSEcCtD
Amitriptyline—Dermatitis—Risedronate—osteoporosis	0.000214	0.00114	CcSEcCtD
Amitriptyline—Dizziness—Pamidronate—osteoporosis	0.000214	0.00114	CcSEcCtD
Amitriptyline—Headache—Risedronate—osteoporosis	0.000213	0.00113	CcSEcCtD
Amitriptyline—Asthenia—Zoledronate—osteoporosis	0.000212	0.00113	CcSEcCtD
Amitriptyline—Pruritus—Zoledronate—osteoporosis	0.000209	0.00111	CcSEcCtD
Amitriptyline—Nausea—Ethinyl Estradiol—osteoporosis	0.000207	0.0011	CcSEcCtD
Amitriptyline—Insomnia—Estradiol—osteoporosis	0.000206	0.0011	CcSEcCtD
Amitriptyline—Vomiting—Pamidronate—osteoporosis	0.000205	0.00109	CcSEcCtD
Amitriptyline—Paraesthesia—Estradiol—osteoporosis	0.000204	0.00109	CcSEcCtD
Amitriptyline—Asthenia—Conjugated Estrogens—osteoporosis	0.000204	0.00109	CcSEcCtD
Amitriptyline—Rash—Pamidronate—osteoporosis	0.000204	0.00108	CcSEcCtD
Amitriptyline—Dermatitis—Pamidronate—osteoporosis	0.000204	0.00108	CcSEcCtD
Amitriptyline—Headache—Pamidronate—osteoporosis	0.000202	0.00108	CcSEcCtD
Amitriptyline—Somnolence—Estradiol—osteoporosis	0.000202	0.00108	CcSEcCtD
Amitriptyline—Diarrhoea—Zoledronate—osteoporosis	0.000202	0.00108	CcSEcCtD
Amitriptyline—Nausea—Risedronate—osteoporosis	0.000202	0.00108	CcSEcCtD
Amitriptyline—Pruritus—Conjugated Estrogens—osteoporosis	0.000201	0.00107	CcSEcCtD
Amitriptyline—Dyspepsia—Estradiol—osteoporosis	0.0002	0.00107	CcSEcCtD
Amitriptyline—Decreased appetite—Estradiol—osteoporosis	0.000198	0.00105	CcSEcCtD
Amitriptyline—Fatigue—Estradiol—osteoporosis	0.000196	0.00104	CcSEcCtD
Amitriptyline—Dizziness—Zoledronate—osteoporosis	0.000195	0.00104	CcSEcCtD
Amitriptyline—Constipation—Estradiol—osteoporosis	0.000194	0.00104	CcSEcCtD
Amitriptyline—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000194	0.00104	CcSEcCtD
Amitriptyline—Nausea—Pamidronate—osteoporosis	0.000192	0.00102	CcSEcCtD
Amitriptyline—Dizziness—Conjugated Estrogens—osteoporosis	0.000188	0.001	CcSEcCtD
Amitriptyline—Vomiting—Zoledronate—osteoporosis	0.000188	0.000999	CcSEcCtD
Amitriptyline—Feeling abnormal—Estradiol—osteoporosis	0.000187	0.000998	CcSEcCtD
Amitriptyline—Rash—Zoledronate—osteoporosis	0.000186	0.000991	CcSEcCtD
Amitriptyline—Dermatitis—Zoledronate—osteoporosis	0.000186	0.00099	CcSEcCtD
Amitriptyline—Headache—Zoledronate—osteoporosis	0.000185	0.000985	CcSEcCtD
Amitriptyline—Vomiting—Conjugated Estrogens—osteoporosis	0.000181	0.000962	CcSEcCtD
Amitriptyline—Urticaria—Estradiol—osteoporosis	0.000181	0.000962	CcSEcCtD
Amitriptyline—Body temperature increased—Estradiol—osteoporosis	0.00018	0.000957	CcSEcCtD
Amitriptyline—Rash—Conjugated Estrogens—osteoporosis	0.000179	0.000954	CcSEcCtD
Amitriptyline—Dermatitis—Conjugated Estrogens—osteoporosis	0.000179	0.000953	CcSEcCtD
Amitriptyline—Headache—Conjugated Estrogens—osteoporosis	0.000178	0.000948	CcSEcCtD
Amitriptyline—Nausea—Zoledronate—osteoporosis	0.000175	0.000934	CcSEcCtD
Amitriptyline—Nausea—Conjugated Estrogens—osteoporosis	0.000169	0.000899	CcSEcCtD
Amitriptyline—Asthenia—Estradiol—osteoporosis	0.000163	0.000869	CcSEcCtD
Amitriptyline—Pruritus—Estradiol—osteoporosis	0.000161	0.000857	CcSEcCtD
Amitriptyline—Diarrhoea—Estradiol—osteoporosis	0.000156	0.000829	CcSEcCtD
Amitriptyline—Dizziness—Estradiol—osteoporosis	0.00015	0.000801	CcSEcCtD
Amitriptyline—Vomiting—Estradiol—osteoporosis	0.000145	0.00077	CcSEcCtD
Amitriptyline—Rash—Estradiol—osteoporosis	0.000143	0.000764	CcSEcCtD
Amitriptyline—Dermatitis—Estradiol—osteoporosis	0.000143	0.000763	CcSEcCtD
Amitriptyline—Headache—Estradiol—osteoporosis	0.000142	0.000759	CcSEcCtD
Amitriptyline—Nausea—Estradiol—osteoporosis	0.000135	0.000719	CcSEcCtD
Amitriptyline—CYP2E1—Metabolism—GPX1—osteoporosis	7.09e-06	5.13e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ADCY5—osteoporosis	7.08e-06	5.12e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—GPX1—osteoporosis	7.07e-06	5.12e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.06e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ADCY5—osteoporosis	7.06e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—LEP—osteoporosis	7.05e-06	5.11e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—POMC—osteoporosis	7.02e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—LEP—osteoporosis	7.02e-06	5.08e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SPP1—osteoporosis	7e-06	5.07e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ADCY5—osteoporosis	6.99e-06	5.06e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	6.97e-06	5.05e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling by GPCR—IL6—osteoporosis	6.97e-06	5.04e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—POMC—osteoporosis	6.95e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—POMC—osteoporosis	6.95e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TPI1—osteoporosis	6.95e-06	5.03e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SPP1—osteoporosis	6.88e-06	4.98e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SPP1—osteoporosis	6.87e-06	4.97e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IRS2—osteoporosis	6.86e-06	4.97e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SPP1—osteoporosis	6.85e-06	4.96e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6R—osteoporosis	6.85e-06	4.96e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SPP1—osteoporosis	6.83e-06	4.94e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6R—osteoporosis	6.78e-06	4.91e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6R—osteoporosis	6.78e-06	4.91e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SPP1—osteoporosis	6.76e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IGF1—osteoporosis	6.75e-06	4.89e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SPP1—osteoporosis	6.74e-06	4.88e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—ESR1—osteoporosis	6.73e-06	4.88e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—LEP—osteoporosis	6.72e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CYP19A1—osteoporosis	6.71e-06	4.86e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—ESR1—osteoporosis	6.7e-06	4.85e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IGF1—osteoporosis	6.69e-06	4.84e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IGF1—osteoporosis	6.69e-06	4.84e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—MTHFR—osteoporosis	6.68e-06	4.83e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CYP19A1—osteoporosis	6.55e-06	4.74e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ENO1—osteoporosis	6.54e-06	4.74e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—MTHFR—osteoporosis	6.54e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—P4HB—osteoporosis	6.53e-06	4.73e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—MTHFR—osteoporosis	6.53e-06	4.72e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	6.47e-06	4.69e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PSMA5—osteoporosis	6.45e-06	4.67e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PSMA2—osteoporosis	6.45e-06	4.67e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GAPDH—osteoporosis	6.41e-06	4.64e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—ESR1—osteoporosis	6.41e-06	4.64e-05	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—TGFB1—osteoporosis	6.39e-06	4.63e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IRS2—osteoporosis	6.33e-06	4.58e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IRS1—osteoporosis	6.29e-06	4.56e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SPP1—osteoporosis	6.26e-06	4.54e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IRS1—osteoporosis	6.26e-06	4.53e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—RAP1A—osteoporosis	6.25e-06	4.52e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IRS2—osteoporosis	6.23e-06	4.51e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IRS2—osteoporosis	6.21e-06	4.5e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—POMC—osteoporosis	6.21e-06	4.49e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IRS2—osteoporosis	6.19e-06	4.48e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—LEP—osteoporosis	6.19e-06	4.48e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CYP19A1—osteoporosis	6.17e-06	4.47e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IRS2—osteoporosis	6.17e-06	4.47e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—MYC—osteoporosis	6.17e-06	4.47e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—TGFB1—osteoporosis	6.15e-06	4.46e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ADCY5—osteoporosis	6.15e-06	4.45e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—GPX1—osteoporosis	6.12e-06	4.43e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CYP19A1—osteoporosis	6.12e-06	4.43e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IRS2—osteoporosis	6.11e-06	4.43e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—ADCY5—osteoporosis	6.11e-06	4.42e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—IL6—osteoporosis	6.11e-06	4.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IRS2—osteoporosis	6.1e-06	4.41e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—LEP—osteoporosis	6.09e-06	4.41e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GPX1—osteoporosis	6.09e-06	4.41e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—LEP—osteoporosis	6.08e-06	4.4e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—LEP—osteoporosis	6.06e-06	4.39e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—POMC—osteoporosis	6.06e-06	4.39e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—LEP—osteoporosis	6.04e-06	4.37e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—POMC—osteoporosis	6.03e-06	4.36e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—IL6—osteoporosis	6.02e-06	4.36e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—IL6—osteoporosis	6.01e-06	4.35e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IRS1—osteoporosis	5.99e-06	4.34e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—LEP—osteoporosis	5.98e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—IL6—osteoporosis	5.98e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—IL6—osteoporosis	5.97e-06	4.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—LEP—osteoporosis	5.97e-06	4.32e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ESR1—osteoporosis	5.91e-06	4.28e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6R—osteoporosis	5.91e-06	4.28e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6R—osteoporosis	5.88e-06	4.26e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—IL6—osteoporosis	5.85e-06	4.24e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IGF1—osteoporosis	5.83e-06	4.22e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ESR1—osteoporosis	5.82e-06	4.21e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ESR1—osteoporosis	5.8e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IGF1—osteoporosis	5.8e-06	4.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ESR1—osteoporosis	5.79e-06	4.19e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—POMC—osteoporosis	5.77e-06	4.18e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ESR1—osteoporosis	5.77e-06	4.18e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ESR1—osteoporosis	5.71e-06	4.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ESR1—osteoporosis	5.7e-06	4.12e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—POMC—osteoporosis	5.69e-06	4.12e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—IL6—osteoporosis	5.68e-06	4.11e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IRS2—osteoporosis	5.66e-06	4.1e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—MTHFR—osteoporosis	5.65e-06	4.09e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6R—osteoporosis	5.63e-06	4.08e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—MTHFR—osteoporosis	5.62e-06	4.07e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IGF1—osteoporosis	5.55e-06	4.02e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—LEP—osteoporosis	5.54e-06	4.01e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IRS1—osteoporosis	5.52e-06	4e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ADCY5—osteoporosis	5.49e-06	3.97e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MYC—osteoporosis	5.47e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GPX1—osteoporosis	5.47e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TGFB1—osteoporosis	5.46e-06	3.95e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—IL6—osteoporosis	5.45e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—IL6—osteoporosis	5.44e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IRS1—osteoporosis	5.44e-06	3.94e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IRS1—osteoporosis	5.42e-06	3.93e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IRS1—osteoporosis	5.41e-06	3.91e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IRS1—osteoporosis	5.39e-06	3.9e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—ADCY5—osteoporosis	5.35e-06	3.88e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—POMC—osteoporosis	5.34e-06	3.87e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IRS1—osteoporosis	5.34e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GPX1—osteoporosis	5.34e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IRS1—osteoporosis	5.32e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—POMC—osteoporosis	5.32e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ESR1—osteoporosis	5.29e-06	3.83e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—POMC—osteoporosis	5.23e-06	3.79e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYP19A1—osteoporosis	5.23e-06	3.79e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—POMC—osteoporosis	5.23e-06	3.79e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—POMC—osteoporosis	5.22e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—POMC—osteoporosis	5.22e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—POMC—osteoporosis	5.21e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—POMC—osteoporosis	5.19e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6R—osteoporosis	5.19e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—IL6—osteoporosis	5.16e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—POMC—osteoporosis	5.14e-06	3.72e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—POMC—osteoporosis	5.12e-06	3.71e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IGF1—osteoporosis	5.12e-06	3.7e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—IL6—osteoporosis	5.11e-06	3.7e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—IL6—osteoporosis	5.11e-06	3.7e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6R—osteoporosis	5.11e-06	3.7e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6R—osteoporosis	5.09e-06	3.69e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6R—osteoporosis	5.08e-06	3.68e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6R—osteoporosis	5.06e-06	3.67e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ENO1—osteoporosis	5.05e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ADCY5—osteoporosis	5.04e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—MTHFR—osteoporosis	5.04e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IGF1—osteoporosis	5.03e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GPX1—osteoporosis	5.03e-06	3.64e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IGF1—osteoporosis	5.02e-06	3.64e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6R—osteoporosis	5.01e-06	3.63e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IGF1—osteoporosis	5.01e-06	3.63e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ADCY5—osteoporosis	5e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6R—osteoporosis	5e-06	3.62e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IGF1—osteoporosis	4.99e-06	3.61e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GPX1—osteoporosis	4.98e-06	3.61e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PSMA5—osteoporosis	4.98e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PSMA2—osteoporosis	4.98e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IRS1—osteoporosis	4.94e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IGF1—osteoporosis	4.94e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IGF1—osteoporosis	4.93e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—MTHFR—osteoporosis	4.92e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MYC—osteoporosis	4.8e-06	3.48e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TGFB1—osteoporosis	4.79e-06	3.47e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—POMC—osteoporosis	4.76e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MYC—osteoporosis	4.73e-06	3.43e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MYC—osteoporosis	4.73e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TGFB1—osteoporosis	4.72e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TGFB1—osteoporosis	4.71e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MYC—osteoporosis	4.7e-06	3.4e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TGFB1—osteoporosis	4.68e-06	3.39e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6R—osteoporosis	4.64e-06	3.36e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—MTHFR—osteoporosis	4.64e-06	3.36e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—IL6—osteoporosis	4.64e-06	3.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—MTHFR—osteoporosis	4.6e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MYC—osteoporosis	4.6e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TGFB1—osteoporosis	4.59e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IGF1—osteoporosis	4.58e-06	3.32e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—POMC—osteoporosis	4.52e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—POMC—osteoporosis	4.49e-06	3.25e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MYC—osteoporosis	4.46e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—IL6—osteoporosis	4.46e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TGFB1—osteoporosis	4.45e-06	3.22e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—IL6—osteoporosis	4.43e-06	3.21e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MYC—osteoporosis	4.27e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ADCY5—osteoporosis	4.27e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TGFB1—osteoporosis	4.26e-06	3.09e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GPX1—osteoporosis	4.26e-06	3.08e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—IL6—osteoporosis	4.24e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IL6—osteoporosis	4.12e-06	2.98e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MYC—osteoporosis	4.06e-06	2.94e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TGFB1—osteoporosis	4.05e-06	2.93e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.04e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—POMC—osteoporosis	4.03e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MYC—osteoporosis	4.02e-06	2.91e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MYC—osteoporosis	4.02e-06	2.91e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TGFB1—osteoporosis	4.01e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	4.01e-06	2.9e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—POMC—osteoporosis	3.94e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MTHFR—osteoporosis	3.93e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—IL6—osteoporosis	3.91e-06	2.83e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—IL6—osteoporosis	3.85e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—IL6—osteoporosis	3.84e-06	2.78e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—IL6—osteoporosis	3.83e-06	2.77e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—IL6—osteoporosis	3.82e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—IL6—osteoporosis	3.78e-06	2.74e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—IL6—osteoporosis	3.77e-06	2.73e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—POMC—osteoporosis	3.71e-06	2.69e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—POMC—osteoporosis	3.68e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL6—osteoporosis	3.61e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—osteoporosis	3.56e-06	2.58e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—osteoporosis	3.55e-06	2.57e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—osteoporosis	3.53e-06	2.56e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—osteoporosis	3.5e-06	2.54e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—osteoporosis	3.5e-06	2.54e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TGFB1—osteoporosis	3.49e-06	2.53e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—osteoporosis	3.48e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TGFB1—osteoporosis	3.48e-06	2.52e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—osteoporosis	3.46e-06	2.5e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—osteoporosis	3.35e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—osteoporosis	3.34e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	3.33e-06	2.41e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ADCY5—osteoporosis	3.3e-06	2.39e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GPX1—osteoporosis	3.29e-06	2.38e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—osteoporosis	3.21e-06	2.33e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—POMC—osteoporosis	3.14e-06	2.28e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—osteoporosis	3.07e-06	2.23e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFB1—osteoporosis	3.07e-06	2.22e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—osteoporosis	3.05e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—osteoporosis	3.03e-06	2.2e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—osteoporosis	3.03e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—osteoporosis	3.02e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—osteoporosis	3.02e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—osteoporosis	3.02e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFB1—osteoporosis	3.02e-06	2.19e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFB1—osteoporosis	3.01e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—osteoporosis	3.01e-06	2.18e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFB1—osteoporosis	3e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—osteoporosis	3e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFB1—osteoporosis	2.99e-06	2.17e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—osteoporosis	2.97e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFB1—osteoporosis	2.96e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—osteoporosis	2.96e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	2.96e-06	2.14e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—osteoporosis	2.75e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	2.75e-06	1.99e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—osteoporosis	2.63e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—osteoporosis	2.62e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—osteoporosis	2.51e-06	1.82e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—POMC—osteoporosis	2.43e-06	1.76e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—osteoporosis	2.31e-06	1.67e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—osteoporosis	2.27e-06	1.65e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—osteoporosis	2.27e-06	1.64e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—osteoporosis	2.26e-06	1.64e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—osteoporosis	2.25e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—osteoporosis	2.23e-06	1.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.23e-06	1.61e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—osteoporosis	2.07e-06	1.5e-05	CbGpPWpGaD
